Scilex’s shareholders as of the record date of November 14, 2025 will receive one meme coin for each common share held. This digital collectible is intended to provide for immutable recognition of ...

Trial results showed that 60-minute pegloticase infusions plus MTX had comparable safety and efficacy to standard 120-minute protocols for managing uncontrolled gout.

A newly identified genetic marker may significantly improve the ability to predict life-threatening reactions to the gout medication allopurinol in U.S. patients.

Atom’s lingdolinurad (ABP-671), a URAT1 inhibitor, is in late stage global clinical trials for chronic gout and ABP-745, an anti-inflammatory drug, is in multi-country Phase 2 trials for acute gout ...

Shanton Pharma, a clinical-stage biotech developing a novel treatment for gout, today announced the successful completion of ...

Many things can increase your chances of getting gout. One major cause is the food you eat. Foods that are high in purines, ...

Gout Gout has won the last races of his school career and been mobbed at the GPS Track and Field Championships. Watch replays ...

A doctor has issued an urgent warning over a popular painkiller as it could be dangerous to certain people. The expert ...

The teen sprint superstar tied the most stylish of bows on his schoolboy career on Friday evening, breaking two records in ...

Way back when Gout Gout was in year seven, long before Australia and the world knew about the boy from Ipswich and his ...

The multi-centre, randomised, double-blind RUBY and TOPAZ studies are assessing the therapy’s performance against allopurinol ...

Results of a Phase 2a dose escalating study of lingdolinurad (ABP-671) for chronic gout, which enrolled patients with mild to moderate renal impairment, showed the URAT1 inhibitor lowered serum uric ...